We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$9.85B
1-Year Est. Return
55.6%
This Fund
S&P 500
This Quarter
Est. Return
+4.03%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$12.6B
AUM Growth
-$2.64B
(-17%)
Cap. Flow
-$3B
Cap. Flow
% of AUM
-23.78%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,463
New
470
Increased
292
Reduced
327
Closed
314
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$628M |
| 2 |
AET
Aetna Inc
AET
|
+$386M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$256M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
+$232M |
| 5 |
IDTI
Integrated Device Technology I
IDTI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.37B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.05B |
| 3 |
XL
XL Group Ltd.
XL
|
+$560M |
| 4 |
COL
Rockwell Collins
COL
|
+$467M |
| 5 |
Qualcomm
QCOM
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Financials | 9.7% |
| 3 | Communication Services | 6.84% |
| 4 | Healthcare | 6.12% |
| 5 | Consumer Discretionary | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Heron Therapeutics
HRTX
$92.9M
| – | – |
-12,400
| Closed | -$482K |
|
1227
Huazhu Hotels Group
HTHT
$13B
| – | – |
-175,275
| Closed | -$7.36M |
|
1228
IAMGOLD
IAG
$10.5B
| – | – |
-29,245
| Closed | -$170K |
|
1229
iShares Biotechnology ETF
IBB
$9.71B
| – | – |
-13,500
| Closed | -$1.48M |
|
1230
ICICI Bank
IBN
$108B
| – | – |
-59,275
| Closed | -$476K |
|
1231
i3 Verticals
IIIV
$342M
| – | – |
-30,000
| Closed | -$457K |
|
1232
Incyte
INCY
$24.4B
| – | – |
-21,872
| Closed | -$1.47M |
|
1233
ING
ING
$102B
| – | – |
-55,792
| Closed | -$799K |
|
1234
Inogen
INGN
$164M
| – | – |
-3,154
| Closed | -$588K |
|
1235
Insmed
INSM
$28.6B
| – | – |
-12,300
| Closed | -$291K |
|
1236
Innoviva
INVA
$1.48B
| – | – |
-209,900
| Closed | -$2.9M |
|
1237
iQIYI
IQ
$1.28B
| – | – |
-150,000
| Closed | -$4.84M |
|
1238
IQVIA
IQV
$39.3B
| – | – |
-13,800
| Closed | -$1.38M |
|
1239
Integer Holdings
ITGR
$4.26B
| – | – |
-25,981
| Closed | -$1.68M |
|
1240
Itaú Unibanco
ITUB
$87.5B
| – | – |
-626,607
| Closed | -$3.15M |
|
1241
iShares US Real Estate ETF
IYR
$4.57B
| – | – |
-95,871
| Closed | -$7.72M |
|
1242
JetBlue
JBLU
$2.29B
| – | – |
-13,950
| Closed | -$265K |
|
1243
Johnson & Johnson
JNJ
$625B
| – | – |
-8,507
| Closed | -$1.03M |
|
|
OPLN
1244
Openlane
OPLN
$4.54B
| – | – |
-11,614
| Closed | -$241K |
|
1245
KB Financial Group
KB
$43.5B
| – | – |
-5,400
| Closed | -$251K |
|
1246
CALL
Keurig Dr Pepper
KDP
$40.8B
| – | – |
-100,000
| Closed | -$12.2M |
|
1247
Coca-Cola
KO
$375B
| – | – |
-8,465
| Closed | -$371K |
|
1248
Kite Realty
KRG
$5.36B
| – | – |
-75,278
| Closed | -$1.29M |
|
1249
Lands' End
LE
$403M
| – | – |
-28,680
| Closed | -$800K |
|
1250
Eli Lilly
LLY
$1.06T
| – | – |
-43,409
| Closed | -$3.7M |
|
Similar funds
MF
MPI
URS
CCM
HRCM
FCM
HL
DCP
HBK Investments's Q3 2018 Portfolio in Review
As of Q3 2018, HBK Investments held 1,463 positions worth $12.6B, down 17% from $15.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
HBK Investments withdrew a net $3B in Q3 2018, closing 314 positions and reducing 327 holdings. Its most notable exit was Celgene Corp, an estimated $1.37B position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 25% a quarter earlier, followed by Financials and Communication Services.
Against the trend, HBK Investments opened a new position in Twenty-First Century Fox, Inc. Class A worth $635M.
- HBK Investments's largest Q3 2018 buy was Twenty-First Century Fox, Inc. Class A: 13,703,100 shares worth $635M.
- HBK Investments added most to Aetna Inc in Q3 2018, an estimated $386M increase.
- HBK Investments's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $1.05B.
- HBK Investments fully exited Celgene Corp in Q3 2018, selling an estimated $1.37B.
- HBK Investments's ten largest holdings make up 48% of its $12.6B portfolio in Q3 2018.
- HBK Investments opened 470 new positions and closed 314 in Q3 2018.
- HBK Investments's portfolio value fell 17% quarter-over-quarter to $12.6B.
Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.